University of Groningenfounded in 1614  -  top 100 university
Close
About usHow to find usdrs. W.J. Plattel

drs. W.J. Plattel

E-mail:
w.j.plattel umcg.nl

Research

Advanced
Advanced

Reset

to
1 - 10 out of 10Page size: 50
  1. 2019
  2. Kahle, X. U., Montes de Jesus, F. M., Kwee, T. C., van Meerten, T., Diepstra, A., Rosati, S., ... Nijland, M. (2019). Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma. Scientific Reports, 9(1), [11073]. https://doi.org/10.1038/s41598-019-47453-5
  3. Plattel, W. J. (2019). Circulating biomarkers in classical Hodgkin lymphoma. [Groningen]: Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.97631424
  4. 2017
  5. Klaassen, S. H. C., Lemmink, H. H., Bijzet, J., Glaudemans, A. W. J. M., Bos, R., Plattel, W., ... Hazenberg, B. P. C. (2017). Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G). Cardiovascular Pathology, 29, 19-22. https://doi.org/10.1016/j.carpath.2017.04.002
  6. 2016
  7. Plattel, W. J., Alsada, Z. N. D., van Imhoff, G. W., Diepstra, A., van den Berg, A., & Visser, L. (2016). Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC. British Journal of Haematology, 175(5), 868-875. https://doi.org/10.1111/bjh.14317
  8. Plattel, W. J., Berg, van den, A., Visser, L., Glaudemans, A., Diepstra, A., & van Imhoff, G. (2016). Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom. Haematologica, 101, 31-31. [T014].
  9. 2014
  10. Liang, Z., Diepstra, A., Xu, C., van Imhoff, G., Plattel, W., Van Den Berg, A., & Visser, L. (2014). Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. PLoS ONE, 9(1), [e87474]. https://doi.org/10.1371/journal.pone.0087474
  11. 2013
  12. Plattel, W., Kluiver, J., Diepstra, A., Visser, L., & van den Berg, A. (2013). The Role of MicroRNAs in Hodgkin's Lymphoma. In MicroRNAs in Medicine (pp. 435-447). Wiley-Blackwell. https://doi.org/10.1002/9781118300312.ch26
  13. 2012
  14. Xu, C., Plattel, W., van den Berg, A., Ruether, N., Huang, X., Wang, M., ... Visser, L. (2012). Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma. Haematologica, 97(4), 572-578. https://doi.org/10.3324/haematol.2011.056101
  15. Plattel, W. J., van den Berg, A., Visser, L., van der Graaf, A-M., Pruim, J., Vos, H., ... van Imhoff, G. W. (2012). Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma. Haematologica, 97(3), 410-415. https://doi.org/10.3324/haematol.2011.053199
  16. 2011
  17. Plattel, W. J., Kluin-Nelemans, H. C., de Bock, G. H., & van Imhoff, G. W. (2011). Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma. Bone marrow transplantation, 46(6), 827-834. https://doi.org/10.1038/bmt.2010.188

ID: 273122

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube